Nicotine pouches carry a range of side effects, from visible white patches inside the mouth to digestive complaints like nausea and bloating, along with the cardiovascular strain that comes with nicotine itself. Because these products are tobacco-free, they avoid many of the toxicants found in cigarettes and traditional smokeless tobacco, but “fewer harmful chemicals” is not the same as “harmless.” The side-effect profile is still being mapped by researchers, and what has emerged so far suggests that regular users should pay attention to their gums, their gut, and their relationship with nicotine dependence.
What Nicotine Pouches Do to Your Mouth
The most consistently documented side effect is localized damage to the oral tissue where the pouch sits. A case series examining users’ mouths found white lesions at the site of pouch placement in every participant. Under a microscope, the tissue showed swelling both inside the cells and in the connective tissue beneath them, along with chronic inflammatory infiltration by immune cells.
1PubMed Central. Oral mucosal changes caused by nicotine pouches: case seriesA broader clinical study found oral lesions in about 79% of nicotine pouch users. These users more frequently showed redness and reported oral symptoms like soreness and irritation compared to users of traditional tobacco-derived pouches, who tended to develop thickened white patches instead.
2PubMed. Oral Lesions and Dental Status in Individuals Using Oral Tobacco-Free Nicotine PouchesGum recession is another concern. Clinical case reports have documented localized gum recession and white plaque-like lesions that correspond precisely to where users habitually place their pouches, pointing to a combination of chemical irritation from nicotine and mechanical pressure from the pouch itself.
3PubMed Central. Localized gingival recession and leukoplakia associated with nicotine pouch use: two clinical case reportsBeyond the surface, nicotine interacts with cells in the gum tissue in ways that may compromise periodontal health over time. It activates receptors on cells in the gum lining, ramps up the production of reactive oxygen species and inflammatory signaling molecules, and can shift the balance of the microbial community in the mouth. The flavoring agents added to pouches appear to make things worse by weakening local immune defenses in gum tissue.
4PubMed Central. Emerging Oral Nicotine Products and Periodontal DiseasesIf you use nicotine pouches regularly and always place them on the same side, rotating the placement site is a practical step, though it does not eliminate the risk. The gum recession documented in case reports was site-specific, so at minimum you are concentrating damage in one spot by keeping the pouch in the same location every time.
Digestive Problems Are Surprisingly Common
Gut complaints do not get the same attention as oral side effects, but they affect a large share of users. A cross-sectional study of over 1,200 nicotine pouch users in Saudi Arabia found that roughly 81% reported at least one gastrointestinal symptom. The most common was bloating, reported by about two-thirds of users, followed by nausea, heartburn, stomach pain, and constipation, each affecting close to half the sample. Diarrhea was the least reported but still affected more than a third.
5Tobacco Prevention and Cessation. Assessing the gastrointestinal and psychological impacts of nicotine pouch use among adults in Saudi Arabia: A cross-sectional studyNicotine stimulates the release of stomach acid and affects gut motility, which explains why heartburn and nausea are so frequently mentioned. Because pouch users swallow saliva containing dissolved nicotine during use, the gastrointestinal tract gets a more direct dose than it would from, say, a nicotine patch. Users who experience persistent nausea or stomach pain often find that switching to a lower-strength pouch reduces symptoms, since the amount of nicotine swallowed drops accordingly.
Acute Reactions and Dose-Dependent Effects
Headache, dizziness, throat irritation, and hiccups are among the most commonly reported immediate side effects. A systematic review of randomized trials involving nicotine pouches found that adverse events were mostly mild and included cough, throat irritation, and headache. These reactions became more frequent at higher nicotine doses, though no serious adverse events were reported across the trials reviewed.
6PubMed. Nicotine pouches and clinical outcomes related to smoking cessation: A systematic review of randomized trialsDose matters more than many users realize. A pharmacokinetic study found that a 30 mg nicotine pouch delivered roughly twice the peak blood nicotine level of a cigarette. Even the rapid absorption phase was comparable to smoking at that dose.
7PubMed Central. Small pouches, but high nicotine doses-nicotine delivery and acute effects after use of tobacco-free nicotine pouches A meta-analysis comparing pouches to cigarettes across multiple trials found that 4 mg pouches, which are among the most commonly used, deliver total nicotine exposure similar to a cigarette but with a lower peak and slower absorption. Pouches containing 8 mg or more exceeded cigarette exposure. Peak nicotine concentration consistently arrived faster with cigarettes (within about five to eight minutes) than with pouches (twenty minutes or longer).
8Drug and Alcohol Dependence Reports. Nicotine pouch pharmacokinetics compared to smoked tobacco: A systematic review and meta-analysisThat slower rise is one reason pouches feel milder to many users, even when the total nicotine they absorb is equivalent to or greater than a cigarette. But it also means a person chasing a quick hit may stack pouches or move to a higher strength, which escalates both acute side effects and dependence risk.
Cardiovascular Effects
Nicotine itself raises heart rate and blood pressure regardless of how it enters the body, and pouches are no exception.
9Quality in Sport. Emerging Nicotine Pouches: Mechanisms of Action, Health Risks, and Regulatory Perspectives – A Systematic Review A review of nicotine’s cardiovascular mechanisms highlighted that the drug triggers sympathetic nervous system activation, impairs the ability of blood vessels to relax properly, and increases arterial stiffness.
10PubMed. Snus, nicotine pouches and cardiovascular disease: Evidence, mechanisms, and the challenge of novel nicotine productsWhat remains uncertain is the size of the long-term cardiovascular risk from nicotine pouches specifically, as opposed to from nicotine delivered by cigarettes or traditional smokeless tobacco. Cigarettes expose the cardiovascular system to carbon monoxide, fine particulate matter, and oxidant gases on top of nicotine. Pouches skip those exposures. The evidence from Swedish snus, the closest historical parallel, suggests that oral nicotine products carry a lower cardiovascular burden than smoking, but “lower than cigarettes” still leaves room for meaningful risk, particularly for people who would not otherwise be using nicotine at all.
An interesting wrinkle comes from a cessation study. When regular snus and nicotine pouch users quit for twelve weeks, their systolic blood pressure actually rose by an average of about 4 mmHg, they gained roughly 1.8 kg of body weight, and a marker of blood sugar control worsened slightly.
11PubMed Central. Cardiovascular and metabolic changes following 12 weeks of tobacco and nicotine pouch cessation: a Swedish cohort study This counterintuitive finding echoes what happens when smokers quit: nicotine suppresses appetite and has metabolic effects, and removing it causes short-term rebounds in weight and some metabolic markers. It does not mean pouches are cardiovascularly protective; it means quitting any nicotine product triggers a metabolic adjustment period.
How the Toxicant Profile Compares to Other Nicotine Products
One of the selling points of nicotine pouches is that they contain no tobacco leaf, which eliminates exposure to many of the most dangerous chemicals in cigarettes and traditional smokeless tobacco. Laboratory analysis of ZYN pouches found that 38 out of 43 tested harmful compounds were below measurable levels. All tested cancer-linked nitrosamines and polycyclic aromatic hydrocarbons came back below the limit of detection. The compounds that were detected, aside from nicotine itself, were formaldehyde, chromium, and ammonia at low concentrations, plus a trace of nickel in one formulation.
12PubMed Central. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs)A separate analysis of a wider range of brands did detect trace amounts of tobacco-specific nitrosamines in some pouches, though the quantities were very small. The highest amounts found per pouch were in the single-digit nanogram range.
13Tobacco Control. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches For context, a single cigarette delivers thousands of nanograms of these same compounds. The source of trace nitrosamines in a tobacco-free product is likely the nicotine extraction process itself, since nicotine is derived from tobacco plants even when the final product contains no tobacco leaf.
In cell-based toxicology tests, nicotine pouch extracts were found to be non-mutagenic, non-genotoxic, and non-cytotoxic using standard assays, in stark contrast to cigarette smoke extracts, which tested positive across the board.
14PubMed Central. In vitro toxicological evaluation of pouched portioned oral nicotine products However, when researchers exposed human gum tissue cells directly to pouch extracts, some products did trigger measurable cytotoxicity, inflammatory gene activation, and shifts in oxidative stress markers. The effects varied by product, which suggests that specific formulations and ingredient combinations matter.
15PubMed Central. Oral nicotine pouches with an aftertaste? Part 2: in vitro toxicity in human gingival fibroblastsFlavor Matters More Than You Might Think
Not all nicotine pouches are equally irritating, and flavor is one reason why. A study testing different flavored pouch extracts on oral gum cells and lung cells found that fruit-flavored pouches caused the most cell death, while menthol flavors triggered the strongest release of a key inflammatory signal. Tobacco-flavored and fruit-flavored pouches both increased the production of reactive oxygen species, but menthol-flavored ones did not.
16PubMed Central. Flavor Classification/Categorization and Differential Toxicity of Oral Nicotine Pouches (ONPs) in Oral Gingival Epithelial Cells and Bronchial Epithelial CellsThe practical takeaway is that switching flavors is not a purely cosmetic choice. Different flavoring chemicals interact with oral tissue in different ways, and the fact that a product is “tobacco-free” does not mean the additives are biologically inert. If you notice one flavor causing more soreness or irritation than another, your mouth is giving you real information about differential tissue response.
Nicotine Dependence and the pH Factor
The side effect users talk about least but may struggle with the most is dependence. Manufacturers can tune how quickly and intensely nicotine hits by adjusting the pH of the pouch. Higher pH converts more nicotine to its freebase form, which crosses oral membranes faster. Measured pH values of popular brands range from about 7.4 to 8.3.
17ACS Omega. Evaluation of Factors Impacting Nicotine Permeation in Oral Nicotine Pouch Products A study analyzing these products noted that by adjusting pH and nicotine salt levels, manufacturers can increase freebase nicotine content, which enhances absorption and user satisfaction but also contributes to dependence and progression to regular use.
18Tobacco Control. Total and unprotonated (freebase) nicotine content in new types of oral ‘tobacco-free’ nicotine productsIn comparison to nicotine replacement therapies like gum, nicotine pouches deliver substantially more nicotine. One pharmacokinetic study found that a single pouch reached roughly double the peak blood nicotine level of a piece of nicotine gum and delivered about twice the total nicotine exposure. The pouch was more comparable to a nicotine lozenge in both peak and total exposure.
19Scientific Reports. A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products This is a meaningful distinction for anyone thinking of pouches as a cessation aid: they deliver nicotine in quantities that sustain dependence far more effectively than the products designed specifically to wean people off nicotine.
Pregnancy and Reproductive Risks
There are no published trials on nicotine pouches specifically during pregnancy, but the closest available evidence comes from research on Swedish snus, which delivers nicotine through the oral mucosa by the same basic mechanism. A systematic review of snus use during pregnancy found that it likely increases the risk of neonatal breathing problems, with about double the odds of neonatal apnea. It also appears to increase the risk of stillbirth, premature birth, lower birth weight (an average reduction of roughly 70 grams), and possibly oral cleft malformations.
20PubMed. Use of Swedish smokeless tobacco during pregnancy: A systematic review of pregnancy and early life health riskA broader systematic review of non-combustible nicotine products during pregnancy came to a similar conclusion: smoke-free products probably increase the risk of some negative birth outcomes, but any effect appears smaller than the effect of smoking.
21PubMed Central. Potential effects of using non-combustible tobacco and nicotine products during pregnancy: a systematic review The key point for anyone who is pregnant or planning to be is that nicotine itself, regardless of delivery method, constricts blood flow to the placenta. The absence of tobacco leaf and smoke in a nicotine pouch does not make it safe during pregnancy.
Risks to Children and Adolescents
Nicotine pouches look like candy to a toddler, and the consequences of accidental ingestion can be serious. A study using U.S. poison control data found that the rate of nicotine pouch ingestions by young children increased by over 760% between 2020 and 2023. Compared to other nicotine product forms, pouches were more likely to result in a serious medical outcome and roughly twice as likely to lead to hospital admission.
22Pediatrics. Nicotine Ingestions Among Young Children: 2010–2023Adolescents face a different kind of risk. Teens experimenting with pouches can develop acute nicotine poisoning, especially with higher-strength products. A case report described two teenagers, ages 13 and 15, who developed dizziness, nausea, vomiting, and loss of consciousness within 20 to 90 minutes of using nicotine pouches. Blood tests confirmed acute nicotine poisoning with serum levels far above typical adult-user concentrations. Both recovered with supportive care.
23PubMed Central. Acute Nicotine Poisoning From Nicotine Pouch Use in Adolescents: A Case Report of Two Pediatric CasesA qualitative study of U.S. youth found that exposure to nicotine pouches comes primarily through friends and online content, with peer pressure as a leading factor driving use. The teens in the study expressed mixed feelings about the products and were generally aware that health risks exist, but that awareness did not consistently prevent use.
24PubMed. United States Youth Perspectives on Zyn Oral Nicotine PouchesThe Dual-Use Problem
Many nicotine pouch users are not exclusive users. They vape, smoke, or use other tobacco products alongside pouches, and this pattern of dual use has its own risk profile. A review of the cardiovascular implications noted that while exclusive pouch use may reduce exposure to combustion-related toxicants compared to cigarettes, dual use maintains chronic nicotine exposure, ongoing sympathetic activation, and endothelial dysfunction, potentially erasing the cardiovascular advantage that switching was supposed to provide.
25PubMed Central. Nicotine pouches and youth: emerging patterns and potential cardiovascular risks – Section: 1 IntroductionThis is where the product’s marketing as a “cleaner” nicotine source runs into a wall. If pouches are added on top of existing nicotine habits rather than replacing them, total nicotine intake goes up and total toxicant exposure may not decrease in any meaningful way. The side-effect profile for dual users is effectively the combined profile of both products, not the reduced-risk profile of pouches alone. Anyone using pouches with the intent to reduce harm should understand that the benefit is contingent on fully replacing the more harmful product, not supplementing it.